H.C. Wainwright analyst Yi Chen lowered the firm’s price target on Co-Diagnostics to $6 from $9 and keeps a Buy rating on the shares post the Q3 results.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CODX: